Reply: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction

Lin Liang,David Bin-Chia Wu,Mohamed Ismail Abdul Aziz,Raymond Wong,David Sim,Kui Toh Gerard Leong,Yong Quek Wei,Doreen Su-Yin Tan,Kwong Ng

Reply: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction

2018

Lin Liang
David Bin-Chia Wu
Mohamed Ismail Abdul Aziz
Raymond Wong
David Sim
Kui Toh Gerard Leong
Yong Quek Wei
Doreen Su-Yin Tan
Kwong Ng

Reply to: https://www.tandfonline.com/doi/full/10.1080/13696998.2018.1503597 Original Article: https://www.tandfonline.com/doi/full/10.1080/13696998.2017.1387119 Cost-effectiveness analyses (CEAs) ...

Keywords:

Sacubitril, Valsartan
Intensive care medicine
Enalapril
Ejection fraction
Heart failure
Medicine
cost effectiveness
Internal medicine
in patient
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations